The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens Peter Volkmer, Andrew J. Gentles, Debashis Sahoo, Piero Dalerba, Siddhartha S. Mitra, Jian Wang, Humberto Contreras-Trujillo, Robin Martin, Justin D. Cohen, Patricia Lovelace, Ferenc A. Scheeren, Mark P. Chao, Kipp Weiskopf, Chad Tang, Anne Kathrin Volkmer, Tejaswitha J. Naik, Theresa A. Storm, Adriane R. Mosley, Badreddin EdrisSeraina M. Schmid, Chris K. Sun, Mei Sze Chua, Oihana Murillo, Pradeep Rajendran, Adriel C. Cha, Robert K. Chin, Dongkyoon Kim, Maddalena Adorno, Tal Raveh, Diane Tseng, Siddhartha Jaiswal, Per Øyvind Enger, Gary K. Steinberg, Gordon Li, Samuel K. So, Ravindra Majeti, Griffith R. Harsh, Matt De Van Rijn, Nelson N.H. Teng, John B. Sunwoo, Ash A. Alizadeh, Michael F. Clarke, Irving L. Weissman

Research output: Contribution to journalArticlepeer-review

658 Scopus citations

Fingerprint Dive into the research topics of 'The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences